| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 8,250 | $30 | $264K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 23,100 | $10 | $231K |
| J3262 | Injection, tocilizumab, 1 mg | 26,240 | $10 | $131.2K |
| J0490 | Injection, belimumab, 10 mg | 3,430 | $40 | $130.4K |
| J0897 | Injection, denosumab, 1 mg | 6,900 | $20 | $124.2K |
| J3111 | Injection, romosozumab-aqqg, 1 mg | 15,120 | $10 | $121K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 850 | $90 | $73.6K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 560 | $60 | $34.3K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 280 | $50 | $12.8K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 120 | $90 | $11.1K |